Biological models of schizophrenia: An update;Les modèles biologiques de la schizophrénie: Mise à jour

Encephale

Volumn 32, Issue 4 I, 2006, Pages 446-451

  Lotstra, F ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Biological models; Neurodevelopmental disorder; Neurotransmitters; Schizophrenia

Indexed keywords

DOPAMINE; GLUTAMIC ACID; SEROTONIN;

AUTOPSY; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HUMAN; LABORATORY TEST; MEDICAL LITERATURE; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; ONSET AGE; REVIEW; SCHIZOPHRENIA;

EID: 33748275273     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0013-7006(06)76185-1     Document Type: Review

References (34)

1. AGHAJANIAN GK, MAREK GJ. Serotonin model of schizophrenia : emerging role of glutamate. Brain Res Rev 2000 ; 31 : 302-12.
2. ALZHEIMER A. Beiträge zur pathologischen Anatomie der Hirnrinde und zur anatomischen Grundlage einiger Psychosen Monatsschr. Psychiatr Neurol 1867 ; 2 : 1763-9.
3. BENES FM. Myelinisation of cortical-hippocampal relays during late adolescence. Schizophr Bull 1989 ; 15 : 585-93.
4. CARLSSON A, LINDQVIST M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963 ; 20 : 140-4.
5. COSTA E, CHEN Y, DAVIS J et al. Reelin and schizophrenia : a disease at the interface of the genome and the epigenome. Mol Intervent 2002 ; 2 : 47-57.
6. DAVIES KL, STEWART DG, FRIEDMAN JI et al. White matter changes in schizophrenia : evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003 ; 60 : 443-56.
7. ERHARDT S, SCHWIELER L, ENGBERG G. Kynurenic acid and schizophrenia. Adv Exp Med Biol 2003 ; 524 : 155-65.
8. FEINBERG I. Schizophrenia : caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982-1983; 17 : 319-34.
9. FREEDMAN R. Schizophrenia. N Engl J Med 2003 ; 349 : 1738-49.
10. GOFF DC, COYLE JT. The emerging role of glutamate in the pathology and treatment of schizophrenia. Am J Psychiatry 2001 ; 158 : 1367-77.
11. GOLDMAN-RAKIC PS, MULY EC III, WILLIAMS GV. D1 receptors in prefrontal cells and circuits. Brain Res Rev 2000 ; 31 : 295-301.
12. GRACE AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity : a hypothesis for the etiology of schizophrenia. Neuroscience 1991 ; 41 : 1-24.
13. HARRISON PJ, OWEN MJ. Genes for schizophrenia ? Recent findings and their pathophysiological implications. Lancet 2003 ; 361 : 417-9.
14. HOLDEN C. Deconstructing schizophrenia. Science 2003 ; 299 : 333-5.
15. HYDE TM, LEWIS SW. The secondary schizophrenia. In : Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford : Blackwell Publisching, 2003 : 187-202.
16. JENTSCH JD, ROTH RH. The neuropsychopharmacology of phencyclidine : from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999 ; 20 : 201-25.
17. LAMBE EK, KRIMER LS, GOLDMAN-RAKIC PS. Differential post-natal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of Rhesus monkey. J Neurosci 2000 ; 20 ; 8780-7.
18. LARUELLE M. Dopamine transmission in the schizophrenic brain in schizophrenia. Hirsch SR, Weinberger DR, eds. Oxford : Blackwell Publishing, 2003 : 365-87.
19. LARUELLE M, ABI-DARGHAM A, VAN DYCK C et al. Dopamine and serotonin transporters in patients with schizophrenia : an imaging study with (1231-β-CIT). Biol Psychiatry 2000 ; 47 : 371-9.
20. LEWIS DA, LIEBERMAN JA. Catching up on schizophrenia : natural history and neurobiology. Neuron 2000 ; 28 : 325-34.
21. MANUEL DIAGNOSTIQUE ET STATISTIQUE DES TROUBLES MENTAUX (DSM III- R). American Psychiatric Association. Paris : Masson, 1989.
22. MANUEL DIAGNOSTIQUE ET STATISTIQUE DES TROUBLES MENTAUX (DSM IV). American Psychiatric Association. Paris : Masson, 1996.
23. ROBERTS GW, ROYSTON MC, WEINBERGER DR. Schizophrenia. In : Graham DI, Lantos PL, eds. Greenfield's Neuropathology. London : Hodder Arnold, 1997 : 897-929.
24. SELEMON LD, GOLDMAN-RAKIC PS. The reduced neuropil hypothesis : a circuit based model of schizophrenia. Biol Psychiatry 1999; 45 : 17-25.
25. SHILLIAM CS, DAWSON LA. The effect of clozapin on extracellular dopamin levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration : comparison with a selective 5-HT(2C) receptor antagonist. Neuropsychopharmacology 2005 ; 30 : 372-80.
26. SOKOLOFF P. L'hypothèse BDNF de la schizophrénie. Recherche et Enseignement à l'Hôpital Sainte-Anne. Paris : Masson- Acanthe, 2003 : 35-47.
27. STEVENS JR. Schizophrenia : reproductive hormones and the brain. Am J Psychiatry 2002 ; 159 : 713-9.
28. TALBOT K, EIDER W, TINSLEY CL et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004 ; 113 : 1353-63.
29. TSAI G, PASSANI LA, SLUSHER BS et al. Abnormal excitatory neurotransmetter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995 ; 52 : 829-36.
30. TSUANG M. Schizophrenia : genes and environment. Biol Psychiatry 2000 ; 47 : 210-20.
31. VANDERZEYPEN F, BIER JC, GENEVROIS CN et al. Démence frontale ou démence précoce ? À propos de l'observation d'un trouble psychotique associé à une détérioration sévère. Encéphale 2003 ; XXIX : 172-80.
32. WEINBERGER DR. Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987 ; 44 : 660-9.
33. WEINBERGER DR, BERMAN KF, ZEC RF. Physiological dysfunction of dorso-lateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986 ; 43 : 114-24.
34. WEINBERGER DR, MARENCO S. Schizophrenia as a developmental disorder in schizophrenia. Hirsch SR, Weinberger DR, eds. Blackwell Publishing, 2003 : 326-48.